MaggieSantos
☆    

Portugal,
2018-07-03 18:41

Posting: # 19015
Views: 480
 

 Topical Drugs- IVRT [Regulatives / Guidelines]

Hello,

Regarding the new draft guidance on acyclovir ointment I have performed an IVRT test to compare the test and reference formulations. I used a Hanson system similar to the ones used for acyclovir creams.

During the validation of the test system, I applied the described parameters on draft guidance for acyclovir cream, namely, IVRT Discrimination Sensitivity, Specificity and Selectivity.

When comparing the lower (2.5%) and upper (7.5%) release rates to the 5% acyclovir ointment (PEG basis), the release rates were nor discriminatory.

As anyone performed this test, what results were obtained and what is the suggested reason for no discriminatory results. What is the impact?:confused:

Kind Regards

MeggieSantos
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,404 posts in 4,122 threads, 1,323 registered users;
online 6 (0 registered, 6 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 19:12 CEST

Those people who think they know everything
are a great annoyance to those of us who do.    Isaac Asimov

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5